Clinical Trial

Neural Mobilization vs Cervical Neuromodulation in DPN

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 22, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a three-arm, assessor-blinded, randomized controlled pilot feasibility trial. The primary goal is to evaluate the feasibility and acceptability of conducting a full-scale randomized controlled trial (RCT) comparing two manual therapy techniques: Manual Neural Mobilization (MNM) and Cervical Neuromodulatory Intervention (CNI) in individuals with Diabetic Peripheral Neuropathy (DPN). While glycemic control is a central part of managing type 2 diabetes, this study explores whether non-pharmacological manual therapies can serve as adjunctive interventions to improve metabolic outcomes. A total of 75 participants were assigned to either MNM, CNI, or standard care for 12 weeks. The study focuses on recruitment rates, adherence, and safety, while also exploring secondary outcomes like blood glucose levels (HbA1c, FBG) and pain intensity.
Protocol Amendment History 1 change
notable Sponsor changed: Isra University, Jordan -> Abeer Abdrabo 2026-04-23
Trial Details
NCT Number NCT07537270
Lead Sponsor Abeer Abdrabo
Conditions Diabetic Peripheral Neuropathy Type 2
Enrollment 75 participants
Start Date 2026-02-05
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-22